Australian University Rankings Guide

Journal of Thoracic Oncology (ERA Journal)

Journal of Thoracic Oncology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Journal of Thoracic Oncology issns are issn1: 1556-0864 issn2: 1556-1380.

The fields covered by Journal of Thoracic Oncology as part of the evaluation of Australian university research excellence are:

Cardiorespiratory Medicine and Haematology Research Rankings (Sub-Field)

Clinical Sciences Research Rankings (Sub-Field)

Oncology and Carcinogenesis Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Cardiorespiratory Medicine and Haematology field include:

- Acta Myologica
- Annals of Hematology
- Annals of Hepatology : official journal of the Mexican Association of Hepatology
- Cardiology: international journal of cardiovascular medicine surgery and pathology
- Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Current Hypertension Reviews
- Echocardiography: a journal of cardiovascular ultrasound and allied techniques
- European Journal of Cardiovascular Nursing
- Journal of Cardiovascular Nursing
- Journal of Interventional Cardiac Electrophysiology: an international journal of arrhythmias and pacing
- Lung India
- Perfusion
- Progress in Pediatric Cardiology
- Spanish Review of Cardiology
- The International Journal of Chronic Obstructive Pulmonary Disease

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4